Caveolin-1 overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma

S. Murakami, M. Miyamoto, Y. Hida, Y. Cho, A. Fukunaga, T. Oshikiri, K. Kato, T. Kurokawa, M. Suzuoki, Y. Nakakubo, K. Hiraoka, T. Itoh, T. Shinohara, T. Morikawa, S. Okushiba, S. Kondo, H. Katoh

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Extrahepatic bile duct carcinoma (EBDC) is a malignancy well known for its poor prognosis. Some clinicopathological prognostic markers have been proposed, but genetic factors have not been well investigated. We have examined expression patterns of caveolin-1, which has been shown to function as a tumour suppressor in vitro, in EBDC using immunohistochemistry. Normal tissues adjacent to the tumour cells did not show immunoreactivity for caveolin-1. A total of 22 of the 60-carcinoma tissue samples (36.7%) studied were positive for caveolin-1. Caveolin-1 immunostaining negatively correlated with the patient's age and pathological T factor (pT) in a statistically significant manner. Multivariate analysis using Cox's proportional hazards model identified caveolin-1 expression as an independent positive prognostic factor. Thus, our study suggests that caveolin-1 expression may be a useful prognostic marker for EBDC.

Original languageEnglish
Pages (from-to)1234-1238
Number of pages5
JournalBritish Journal of Cancer
Volume88
Issue number8
Publication statusPublished - 22-04-2003
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Caveolin-1 overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma'. Together they form a unique fingerprint.

Cite this